Journal article · 2022
Case study: treatment-resistant schizophrenia
Pharmaceutical journal/The pharmaceutical journal · Published 1 January 2022 · DOI 10.1211/pj.2021.1.121281
In brief
“Case study: treatment-resistant schizophrenia” is a 2022 journal article, published in Pharmaceutical journal/The pharmaceutical journal. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
Abstract
Background Around 0.5–0.7% of the UK population is living with schizophrenia. Of these individuals, up to one-third are classified as treatment-resistant. This is defined as schizophrenia that has not responded to two different antipsychotics[1,2]. Clozapine is the most effective treatment for such patients[3]. It is recommended by the National Institute for Health and Care Excellence… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Case study: treatment-resistant schizophrenia. (2022). Pharmaceutical journal/The pharmaceutical journal. https://doi.org/10.1211/pj.2021.1.121281
MLA 9
“Case study: treatment-resistant schizophrenia.” Pharmaceutical journal/The pharmaceutical journal, 2022. https://doi.org/10.1211/pj.2021.1.121281.
Chicago
2022. “Case study: treatment-resistant schizophrenia.” Pharmaceutical journal/The pharmaceutical journal. https://doi.org/10.1211/pj.2021.1.121281.
Harvard
(2022) ‘Case study: treatment-resistant schizophrenia’, Pharmaceutical journal/The pharmaceutical journal. doi:10.1211/pj.2021.1.121281.
IEEE
“Case study: treatment-resistant schizophrenia,” Pharmaceutical journal/The pharmaceutical journal, 2022, doi: 10.1211/pj.2021.1.121281.
BibTeX
@article{anon2022case,
title = {{Case study: treatment-resistant schizophrenia}},
journal = {Pharmaceutical journal/The pharmaceutical journal},
year = {2022},
doi = {10.1211/pj.2021.1.121281},
url = {https://doi.org/10.1211/pj.2021.1.121281}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- treatment-resistant schizophrenia
- clozapine
- antipsychotic drugs
- antipsychotic non-response
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Case study: treatment-resistant schizophrenia. (2022). Pharmaceutical journal/The pharmaceutical journal. https://doi.org/10.1211/pj.2021.1.121281
How many times has this paper been cited?
0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
What is the DOI of this paper?
10.1211/pj.2021.1.121281, permanently at https://doi.org/10.1211/pj.2021.1.121281. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.